COVID19 Test Kits Market Overview
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The first case of the disease was reported in December 2019 in Wuhan, China and since then it has spread to various parts of the world, infecting millions.
The global COVID19 Test Kits market is projected to witness tremendous growth due to the rising cases and need for testing. The increasing prevalence of Coronavirus Disease (COVID-19) across different parts of the world is the key reason to boost the growth of the global COVID19 Test Kits market. On 11 March 2020, WHO declared Novel Coronavirus Disease (COVID-19) outbreak as a pandemic and reiterated the call for countries to take immediate actions and scale up the response to treat, detect and reduce transmission to save people’s lives.
Additionally, governments across the world are trying to avail testing kits in the shortest time so that they can quickly test for the disease and take necessary precautions and provide treatment to combat its spread. This crucial factor majorly contributes to the growth of the global COVID19 Test Kits market. Furthermore, several pharmaceutical and biotechnology companies are collaborating to increase the production of coronavirus testing kits. This prime factor positively impacting on the development of the global COVID19 Test Kits market.
Covid-19 Impact on COVID19 Test Kits Market:
In addition, the current COVID19 Test Kits Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the COVID19 Test Kits Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
COVID19 Test Kits Market Segment Overview
Based on technology, the RT-PCR segment is expected to dominate the COVID19 Test Kits market during the forecast period on account of its accuracy, specificity, and sensitivity. Additionally, RT-PCR can detect as little as one virus particle present in the swab. Moreover, the private or commercial labs segment is anticipated to register significant growth since such laboratories have got approval in many countries for aggressive COVID-19 testing.
COVID19 Test Kits Market, By Type of Test
· Molecular
· Serological
COVID19 Test Kits Market, By Use
· Multiple Test
· Single Test
COVID19 Test Kits Market, By Full Test Time
· 1 Hour- 5 Hours
· 5 Hours-12Hours
· 15-60Minutes
· Less than 15 Minutes
· 12 Hours-24Hours
· More Than 1 Days
COVID19 Test Kits Market, By Technology
· RT-PCR
· Rapid Testing Kits
· ELISA Test
· Others
COVID19 Test Kits Market, By Specimen Type
· Nasopharyngeal specimen
· Oropharyngeal specimen
· Blood
· Sputum
· Others
COVID19 Test Kits Market, By Mobility
· Stationary
· Mobile
COVID19 Test Kits Market, By End-User
· Public Health Labs
· Hospitals
· Private or commercial Labs
· Physician Labs
· Others
COVID19 Test Kits Regional Overview
In terms of region, Europe dominates the global COVID19 Test Kits market. This can be attributed to the presence of many pharmaceutical and biotechnology companies such as Altona Diagnostics GmbH, Roche Holding AG, Siemens, among others in the region. These companies are rapidly manufacturing and supplying coronavirus testing kits. Additionally, Europe was the first region to develop RT-PCR-based coronavirus testing kits. Similarly, the market of the Asia Pacific is projected to grow at the fastest rate owing to the increasing incidence of coronavirus and new product launches.
COVID19 Test Kits Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
COVID19 Test Kits Market Competitor overview
Some key developments and strategies adopted by manufacturers in COVID19 Test Kits are highlighted below.
· In March 2020, Abbott announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes. The test will run on the company's ID NOW™ platform, providing rapid results in a wide range of healthcare settings such as physicians' offices, urgent care clinics, and hospital emergency departments.
COVID19 Test Kits Market, Key Players
· Abbott Laboratories
· Altona Diagnostics GmbH
· Roche Holding AG
· BioMedomics Inc.
· Getein Biotech Inc
· Hangzhou Biotest Biotech Company Ltd.
· AmonMed Biotechnology Co. Ltd.
· Beijing Tigsun Diagnostics Co Ltd.
· CTK Biotech Inc.
· Hunan Lituo Biotechnology Co. Ltd.
· Vivacheck Labaratories Inc.
· Thermo Fisher Scientific Inc.
· Siemens AG
· Seegene Technologies Inc.
· FastSense Diagnostics Pvt. Ltd.
· Quest Diagnostics Inc.
· Quidel Corporation
· Becton Dickinson and Company
· QIAGEN N.V.
· PerkinElmer Inc.
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The first case of the disease was reported in December 2019 in Wuhan, China and since then it has spread to various parts of the world, infecting millions.
The global COVID19 Test Kits market is projected to witness tremendous growth due to the rising cases and need for testing. The increasing prevalence of Coronavirus Disease (COVID-19) across different parts of the world is the key reason to boost the growth of the global COVID19 Test Kits market. On 11 March 2020, WHO declared Novel Coronavirus Disease (COVID-19) outbreak as a pandemic and reiterated the call for countries to take immediate actions and scale up the response to treat, detect and reduce transmission to save people’s lives.
Additionally, governments across the world are trying to avail testing kits in the shortest time so that they can quickly test for the disease and take necessary precautions and provide treatment to combat its spread. This crucial factor majorly contributes to the growth of the global COVID19 Test Kits market. Furthermore, several pharmaceutical and biotechnology companies are collaborating to increase the production of coronavirus testing kits. This prime factor positively impacting on the development of the global COVID19 Test Kits market.
Covid-19 Impact on COVID19 Test Kits Market:
In addition, the current COVID19 Test Kits Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the COVID19 Test Kits Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
COVID19 Test Kits Market Segment Overview
Based on technology, the RT-PCR segment is expected to dominate the COVID19 Test Kits market during the forecast period on account of its accuracy, specificity, and sensitivity. Additionally, RT-PCR can detect as little as one virus particle present in the swab. Moreover, the private or commercial labs segment is anticipated to register significant growth since such laboratories have got approval in many countries for aggressive COVID-19 testing.
COVID19 Test Kits Market, By Type of Test
· Molecular
· Serological
COVID19 Test Kits Market, By Use
· Multiple Test
· Single Test
COVID19 Test Kits Market, By Full Test Time
· 1 Hour- 5 Hours
· 5 Hours-12Hours
· 15-60Minutes
· Less than 15 Minutes
· 12 Hours-24Hours
· More Than 1 Days
COVID19 Test Kits Market, By Technology
· RT-PCR
· Rapid Testing Kits
· ELISA Test
· Others
COVID19 Test Kits Market, By Specimen Type
· Nasopharyngeal specimen
· Oropharyngeal specimen
· Blood
· Sputum
· Others
COVID19 Test Kits Market, By Mobility
· Stationary
· Mobile
COVID19 Test Kits Market, By End-User
· Public Health Labs
· Hospitals
· Private or commercial Labs
· Physician Labs
· Others
COVID19 Test Kits Regional Overview
In terms of region, Europe dominates the global COVID19 Test Kits market. This can be attributed to the presence of many pharmaceutical and biotechnology companies such as Altona Diagnostics GmbH, Roche Holding AG, Siemens, among others in the region. These companies are rapidly manufacturing and supplying coronavirus testing kits. Additionally, Europe was the first region to develop RT-PCR-based coronavirus testing kits. Similarly, the market of the Asia Pacific is projected to grow at the fastest rate owing to the increasing incidence of coronavirus and new product launches.
COVID19 Test Kits Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
COVID19 Test Kits Market Competitor overview
Some key developments and strategies adopted by manufacturers in COVID19 Test Kits are highlighted below.
· In March 2020, Abbott announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes. The test will run on the company's ID NOW™ platform, providing rapid results in a wide range of healthcare settings such as physicians' offices, urgent care clinics, and hospital emergency departments.
COVID19 Test Kits Market, Key Players
· Abbott Laboratories
· Altona Diagnostics GmbH
· Roche Holding AG
· BioMedomics Inc.
· Getein Biotech Inc
· Hangzhou Biotest Biotech Company Ltd.
· AmonMed Biotechnology Co. Ltd.
· Beijing Tigsun Diagnostics Co Ltd.
· CTK Biotech Inc.
· Hunan Lituo Biotechnology Co. Ltd.
· Vivacheck Labaratories Inc.
· Thermo Fisher Scientific Inc.
· Siemens AG
· Seegene Technologies Inc.
· FastSense Diagnostics Pvt. Ltd.
· Quest Diagnostics Inc.
· Quidel Corporation
· Becton Dickinson and Company
· QIAGEN N.V.
· PerkinElmer Inc.
COVID19 Test Kits Market Study Global Market Analysis, Insights and Forecast, 2020-2027
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global COVID19 Test Kits Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Type of Test
- 5.2.1. Molecular
- 5.2.2. Serological
- 5.3. Market Analysis, Insights and Forecast – By Use
- 5.3.1. Multiple Test
- 5.3.2. Single Test
- 5.4. Market Analysis, Insights and Forecast – By Full Test Time
- 5.4.1. 1 Hour- 5 Hours
- 5.4.2. 5 Hours-12Hours
- 5.4.3. 15-60Minutes
- 5.4.4. Less than 15 Minutes
- 5.4.5. 12 Hours-24Hours
- 5.4.6. More Than 1 Days
- 5.5. Market Analysis, Insights and Forecast – By Technology
- 5.5.1. RT-PCR
- 5.5.2. Rapid Testing Kits
- 5.5.3. ELISA Test
- 5.5.4. Others
- 5.6. Market Analysis, Insights and Forecast – By Specimen Type
- 5.6.1. Nasopharyngeal specimen
- 5.6.2. Oropharyngeal specimen
- 5.6.3. Blood
- 5.6.4. Sputum
- 5.6.5. Others
- 5.7. Market Analysis, Insights and Forecast – By Mobility
- 5.7.1. Stationary
- 5.7.2. Mobile
- 5.8. Market Analysis, Insights and Forecast – By End-User
- 5.8.1. Public Health Labs
- 5.8.2. Hospitals
- 5.8.3. Private or commercial Labs
- 5.8.4. Physician Labs
- 5.8.5. Others
- 5.9. Market Analysis, Insights and Forecast – By Region
- 5.9.1. North America
- 5.9.2. Europe
- 5.9.3. Asia Pacific
- 5.9.4. Latin America, Middle East and Africa
6. North America COVID19 Test Kits Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Type of Test
- 6.2.1. Molecular
- 6.2.2. Serological
- 6.3. Market Analysis, Insights and Forecast – By Use
- 6.3.1. Multiple Test
- 6.3.2. Single Test
- 6.4. Market Analysis, Insights and Forecast – By Full Test Time
- 6.4.1. 1 Hour- 5 Hours
- 6.4.2. 5 Hours-12Hours
- 6.4.3. 15-60Minutes
- 6.4.4. Less than 15 Minutes
- 6.4.5. 12 Hours-24Hours
- 6.4.6. More Than 1 Days
- 6.5. Market Analysis, Insights and Forecast – By Technology
- 6.5.1. RT-PCR
- 6.5.2. Rapid Testing Kits
- 6.5.3. ELISA Test
- 6.5.4. Others
- 6.6. Market Analysis, Insights and Forecast – By Specimen Type
- 6.6.1. Nasopharyngeal specimen
- 6.6.2. Oropharyngeal specimen
- 6.6.3. Blood
- 6.6.4. Sputum
- 6.6.5. Others
- 6.7. Market Analysis, Insights and Forecast – By Mobility
- 6.7.1. Stationary
- 6.7.2. Mobile
- 6.8. Market Analysis, Insights and Forecast – By End-User
- 6.8.1. Public Health Labs
- 6.8.2. Hospitals
- 6.8.3. Private or commercial Labs
- 6.8.4. Physician Labs
- 6.8.5. Others
- 6.9. Market Analysis, Insights and Forecast – By Country
- 6.9.1. U.S.
- 6.9.2. Canada
7. Europe COVID19 Test Kits Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Type of Test
- 7.2.1. Molecular
- 7.2.2. Serological
- 7.3. Market Analysis, Insights and Forecast – By Use
- 7.3.1. Multiple Test
- 7.3.2. Single Test
- 7.4. Market Analysis, Insights and Forecast – By Full Test Time
- 7.4.1. 1 Hour- 5 Hours
- 7.4.2. 5 Hours-12Hours
- 7.4.3. 15-60Minutes
- 7.4.4. Less than 15 Minutes
- 7.4.5. 12 Hours-24Hours
- 7.4.6. More Than 1 Days
- 7.5. Market Analysis, Insights and Forecast – By Technology
- 7.5.1. RT-PCR
- 7.5.2. Rapid Testing Kits
- 7.5.3. ELISA Test
- 7.5.4. Others
- 7.6. Market Analysis, Insights and Forecast – By Specimen Type
- 7.6.1. Nasopharyngeal specimen
- 7.6.2. Oropharyngeal specimen
- 7.6.3. Blood
- 7.6.4. Sputum
- 7.6.5. Others
- 7.7. Market Analysis, Insights and Forecast – By Mobility
- 7.7.1. Stationary
- 7.7.2. Mobile
- 7.8. Market Analysis, Insights and Forecast – By End-User
- 7.8.1. Public Health Labs
- 7.8.2. Hospitals
- 7.8.3. Private or commercial Labs
- 7.8.4. Physician Labs
- 7.8.5. Others
- 7.9. Market Analysis, Insights and Forecast – By Country
- 7.9.1. UK
- 7.9.2. Germany
- 7.9.3. France
- 7.9.4. Italy
- 7.9.5. Spain
- 7.9.6. Russia
- 7.9.7. Rest of Europe
8. Asia Pacific COVID19 Test Kits Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Type of Test
- 8.2.1. Molecular
- 8.2.2. Serological
- 8.3. Market Analysis, Insights and Forecast – By Use
- 8.3.1. Multiple Test
- 8.3.2. Single Test
- 8.4. Market Analysis, Insights and Forecast – By Full Test Time
- 8.4.1. 1 Hour- 5 Hours
- 8.4.2. 5 Hours-12Hours
- 8.4.3. 15-60Minutes
- 8.4.4. Less than 15 Minutes
- 8.4.5. 12 Hours-24Hours
- 8.4.6. More Than 1 Days
- 8.5. Market Analysis, Insights and Forecast – By Technology
- 8.5.1. RT-PCR
- 8.5.2. Rapid Testing Kits
- 8.5.3. ELISA Test
- 8.5.4. Others
- 8.6. Market Analysis, Insights and Forecast – By Specimen Type
- 8.6.1. Nasopharyngeal specimen
- 8.6.2. Oropharyngeal specimen
- 8.6.3. Blood
- 8.6.4. Sputum
- 8.6.5. Others
- 8.7. Market Analysis, Insights and Forecast – By Mobility
- 8.7.1. Stationary
- 8.7.2. Mobile
- 8.8. Market Analysis, Insights and Forecast – By End-User
- 8.8.1. Public Health Labs
- 8.8.2. Hospitals
- 8.8.3. Private or commercial Labs
- 8.8.4. Physician Labs
- 8.8.5. Others
- 8.9. Market Analysis, Insights and Forecast – By Country
- 8.9.1. China
- 8.9.2. India
- 8.9.3. Japan
- 8.9.4. Australia
- 8.9.5. South East Asia
- 8.9.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa COVID19 Test Kits Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Type of Test
- 9.2.1. Molecular
- 9.2.2. Serological
- 9.3. Market Analysis, Insights and Forecast – By Use
- 9.3.1. Multiple Test
- 9.3.2. Single Test
- 9.4. Market Analysis, Insights and Forecast – By Full Test Time
- 9.4.1. 1 Hour- 5 Hours
- 9.4.2. 5 Hours-12Hours
- 9.4.3. 15-60Minutes
- 9.4.4. Less than 15 Minutes
- 9.4.5. 12 Hours-24Hours
- 9.4.6. More Than 1 Days
- 9.5. Market Analysis, Insights and Forecast – By Technology
- 9.5.1. RT-PCR
- 9.5.2. Rapid Testing Kits
- 9.5.3. ELISA Test
- 9.5.4. Others
- 9.6. Market Analysis, Insights and Forecast – By Specimen Type
- 9.6.1. Nasopharyngeal specimen
- 9.6.2. Oropharyngeal specimen
- 9.6.3. Blood
- 9.6.4. Sputum
- 9.6.5. Others
- 9.7. Market Analysis, Insights and Forecast – By Mobility
- 9.7.1. Stationary
- 9.7.2. Mobile
- 9.8. Market Analysis, Insights and Forecast – By End-User
- 9.8.1. Public Health Labs
- 9.8.2. Hospitals
- 9.8.3. Private or commercial Labs
- 9.8.4. Physician Labs
- 9.8.5. Others
- 9.9. Market Analysis, Insights and Forecast – By Country
- 9.9.1. Brazil
- 9.9.2. Saudi Arabia
- 9.9.3. UAE
- 9.9.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Abbott Laboratories
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Altona Diagnostics GmbH
- 10.6. Roche Holding AG
- 10.7. BioMedomics Inc.
- 10.8. Getein Biotech Inc
- 10.9. Hangzhou Biotest Biotech Company Ltd.
- 10.10. AmonMed Biotechnology Co. Ltd.
- 10.11. Beijing Tigsun Diagnostics Co Ltd.
- 10.12. CTK Biotech Inc.
- 10.13. Hunan Lituo Biotechnology Co. Ltd.
- 10.14. Vivacheck Labaratories Inc.
- 10.15. Thermo Fisher Scientific Inc.
- 10.16. Siemens AG
- 10.17. Seegene Technologies Inc.
- 10.18. FastSense Diagnostics Pvt. Ltd.
- 10.19. Quest Diagnostics Inc.
- 10.20. Quidel Corporation
- 10.21. Becton Dickinson and Company
- 10.22. QIAGEN N.V.
Research Process
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
